Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.062021967516749e-45,34.441972562106045,3543.8255576245942,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",8.000645233964986e-43,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.2516353475573797e-27,16.364197530864196,1013.6858868415975,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.4281725742613167e-25,0,0,51
3,Oxidative phosphorylation WP623,1.6422145961033954e-16,15.419692128957305,560.4335798656807,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",2.1239308776270582e-14,0,0,30
4,Nonalcoholic fatty liver disease WP4396,1.400723443510583e-13,5.560171596297133,164.56227119379065,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'PPARA']",1.3587017402052656e-11,0,0,42
5,Mitochondrial CIV Assembly WP4922,4.638541204140409e-08,9.907426839221174,167.29959183849667,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'SMIM20', 'COX20']",3.5284964439431908e-06,0,0,16
6,Mitochondrial complex I assembly model OXPHOS system WP4324,5.45643779991215e-08,6.574102770718404,109.9445359855236,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",3.5284964439431908e-06,0,0,20
7,Mitochondrial complex III assembly WP4921,0.005278351794013321,5.518172377985462,28.93807616576704,"['UQCRB', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.29257149943959554,0,0,6
8,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.012911040628528379,16.518633540372672,71.85064556875787,"['GSTP1', 'EPHX2', 'COX5A']",0.5150919896690305,0,0,3
9,Glutathione metabolism WP100,0.012911040628528379,16.518633540372672,71.85064556875787,"['GPX4', 'IDH1', 'GSS']",0.5150919896690305,0,0,3
10,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.013275566744047179,7.346459412780656,31.750148832202928,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.5150919896690305,0,0,4
11,Synaptic Vesicle Pathway WP2267,0.02286098342520478,2.759625390218522,10.426757744721883,"['UNC13B', 'UNC13C', 'SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1']",0.8063692335435868,0,0,8
12,Transcription co-factors SKI and SKIL protein partners WP4533,0.028589340625413948,8.25776397515528,29.354049790412116,"['LATS1', 'MERTK', 'STK3']",0.9243886802217177,0,0,3
13,Hippo-Yap signaling pathway WP4537,0.03698636586538687,4.406217616580311,14.52820682945982,"['LATS1', 'NF2', 'TNIK', 'STK3']",0.999266570014494,0,0,4
14,Base Excision Repair WP4752,0.04675097727413013,2.755970924195223,8.441318791665582,"['POLE4', 'PCNA', 'NEIL2', 'MPG', 'TDG', 'POLD2']",0.999266570014494,0,0,6
15,Cellular Proteostasis WP4918,0.05070299466908725,5.504140786749482,16.412083545192075,"['VBP1', 'PFDN4', 'PFDN6']",0.999266570014494,0,0,3
16,Cytosine methylation WP3585,0.06386157511820661,11.001034126163391,30.26425661482846,"['IDH1', 'TDG']",0.999266570014494,0,0,2
17,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.06386157511820661,11.001034126163391,30.26425661482846,"['EPHX2', 'PPARA']",0.999266570014494,0,0,2
18,Metastatic brain tumor WP2249,0.06386157511820661,11.001034126163391,30.26425661482846,"['CDK6', 'E2F3']",0.999266570014494,0,0,2
19,Translation Factors WP107,0.06637104987104327,2.1005896635449184,5.697837517344882,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.999266570014494,0,0,8
20,Glycolysis in senescence WP5049,0.07877359816220525,4.127329192546584,10.488275612650149,"['LDHA', 'ALDOC', 'HK1']",0.999266570014494,0,0,3
21,Nanomaterial induced apoptosis WP2507,0.07877359816220525,4.127329192546584,10.488275612650149,"['ENDOG', 'CASP6', 'CYCS']",0.999266570014494,0,0,3
22,Type II diabetes mellitus WP1584,0.07877359816220525,4.127329192546584,10.488275612650149,"['SURF1', 'PRKCD', 'PHKA2']",0.999266570014494,0,0,3
23,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.09959493379291029,2.7523316062176164,6.3486491337987845,"['MDH2', 'IDH3G', 'OGDH', 'IDH3A']",0.999266570014494,0,0,4
24,Amino Acid metabolism WP3925,0.1075944331837066,1.836975372875477,4.095327856116723,"['LARS2', 'LDHA', 'MDH2', 'IDH1', 'GSS', 'ODC1', 'OGDH', 'GLS']",0.999266570014494,0,0,8
25,DNA Mismatch Repair WP531,0.11202937270046913,3.301242236024845,7.226400060628642,"['POLE4', 'PCNA', 'POLD2']",0.999266570014494,0,0,3
26,Acetylcholine Synthesis WP528,0.11481216182224263,5.499482936918304,11.903399076941245,"['ACHE', 'CHKA']",0.999266570014494,0,0,2
27,Apoptosis Modulation by HSP70 WP384,0.11481216182224263,5.499482936918304,11.903399076941245,"['CASP6', 'CYCS']",0.999266570014494,0,0,2
28,DNA IR-double strand breaks and cellular response via ATM WP3959,0.13064252480843336,1.9435587319039764,3.955706631105651,"['LATS1', 'ATF2', 'DCLRE1C', 'PCNA', 'TRIM28', 'STK3']",0.999266570014494,0,0,6
29,One-carbon metabolism and related pathways WP3940,0.13119981964147853,2.1173795084583467,4.3004693007388735,"['DHFR2', 'GPX4', 'CHKA', 'GSS', 'ETNK1']",0.999266570014494,0,0,5
30,Hematopoietic Stem Cell Differentiation WP2849,0.1495508940154237,2.750517598343685,5.226309416886189,"['SEC14L2', 'PIM1', 'ACVR1B']",0.999266570014494,0,0,3
31,Mitochondrial Gene Expression WP391,0.1495508940154237,2.750517598343685,5.226309416886189,"['CAMK4', 'PPRC1', 'PPARGC1B']",0.999266570014494,0,0,3
32,Type II interferon signaling (IFNG) WP619,0.1495508940154237,2.750517598343685,5.226309416886189,"['PRKCD', 'IRF2', 'HLA-B']",0.999266570014494,0,0,3
33,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.1540782928591032,inf,inf,['TRAF3'],0.999266570014494,0,0,1
34,Glucuronidation WP698,0.1540782928591032,inf,inf,['HK1'],0.999266570014494,0,0,1
35,Energy Metabolism WP1541,0.15672378759093358,1.9657676348547717,3.6430988485910483,"['ATF2', 'CAMK4', 'PPRC1', 'PPARA', 'PPARGC1B']",0.999266570014494,0,0,5
36,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.1573194495601875,2.201036269430052,4.070765582915251,"['LATS1', 'ITGB5', 'NF2', 'STK3']",0.999266570014494,0,0,4
37,Oxidative Damage WP3941,0.1573194495601875,2.201036269430052,4.070765582915251,"['PCNA', 'BAD', 'TRAF3', 'CYCS']",0.999266570014494,0,0,4
38,Ferroptosis WP4313,0.18408342382631404,1.8343706777316735,3.1044269951982217,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'ATG7']",0.999266570014494,0,0,5
39,Parkinson's disease pathway WP2371,0.18988593875648266,2.0005652378709375,3.323602466441462,"['CASP6', 'CYCS', 'PARK7', 'UBE2J1']",0.999266570014494,0,0,4
40,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.21302402278004579,1.7193983402489628,2.658792202240451,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.999266570014494,0,0,5
41,CAMKK2  Pathway WP4874,0.22433276644661626,1.8335060449050087,2.7404035414786447,"['FIS1', 'MAP1LC3A', 'CAMK4', 'SQSTM1']",0.999266570014494,0,0,4
42,Histone Modifications WP2369,0.22433276644661626,1.8335060449050087,2.7404035414786447,"['SET', 'SETDB1', 'SETDB2', 'KMT5A']",0.999266570014494,0,0,4
43,7q11.23 copy number variation syndrome WP4932,0.23299748282392416,1.3764337851929094,2.0050891241119704,"['ATP5F1A', 'PCNA', 'ATP5F1B', 'ATP5MC2', 'OGDH', 'ATP5PO', 'SQSTM1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.999266570014494,0,0,10
44,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.23308961949529416,2.74870734229576,4.003031193315774,"['MAP1LC3A', 'ATG7']",0.999266570014494,0,0,2
45,Nanoparticle triggered autophagic cell death WP2509,0.23308961949529416,2.74870734229576,4.003031193315774,"['MAP1LC3A', 'ATG7']",0.999266570014494,0,0,2
46,Serotonin and anxiety-related events WP3944,0.23308961949529416,2.74870734229576,4.003031193315774,"['CRH', 'HTR2C']",0.999266570014494,0,0,2
47,Thiamine metabolic pathways WP4297,0.23308961949529416,2.74870734229576,4.003031193315774,"['BCKDK', 'OGDH']",0.999266570014494,0,0,2
48,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.2335485937027527,2.062111801242236,2.999063463758298,"['IDH1', 'OGDH', 'IDH3A']",0.999266570014494,0,0,3
49,B Cell Receptor Signaling Pathway WP23,0.2376202663547804,1.481608827762674,2.129192487009233,"['ATF2', 'BCL6', 'CD81', 'PRKCD', 'CAMK2A', 'PIP5K1A', 'E2F3']",0.999266570014494,0,0,7
50,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.24327590958950782,1.617952160117159,2.287070917342002,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'PIN1']",0.999266570014494,0,0,5
51,Metapathway biotransformation Phase I and II WP702,0.24450750325463302,1.4202947198818434,2.0004982966689835,"['CYP4Z1', 'GPX4', 'GSTO1', 'EPHX2', 'GSTP1', 'GSS', 'NDST3', 'KCNAB3']",0.999266570014494,0,0,8
52,DNA Repair Pathways Full Network WP4946,0.2493832637493208,1.3760416666666666,1.910997616347569,"['POLE4', 'DCLRE1C', 'NEIL2', 'PCNA', 'CENPX', 'MPG', 'TDG', 'POLD2', 'GTF2H5']",0.999266570014494,0,0,9
53,Proteasome Degradation WP183,0.2625748801882277,1.4264649264649265,1.9074959736434498,"['PSMB6', 'PSMC5', 'PSMB5', 'PSMB3', 'PSMC1', 'HLA-B', 'PSMB10']",0.999266570014494,0,0,7
54,Selenium Micronutrient Network WP15,0.27456295943204034,1.5277777777777777,1.9747668782164083,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOH']",0.999266570014494,0,0,5
55,White fat cell differentiation WP4149,0.27819981246848424,1.8326432022084196,2.3447124369887082,"['IRF3', 'DDIT3', 'NR2F2']",0.999266570014494,0,0,3
56,Apoptosis WP254,0.2830338124994575,1.434918054991196,1.8111376553084115,"['IRF3', 'CASP6', 'TRAF3', 'BAD', 'IRF2', 'CYCS']",0.999266570014494,0,0,6
57,15q11.2 copy number variation syndrome WP4940,0.28443724528595815,5.494834710743802,6.908340436043771,['TUBGCP4'],0.999266570014494,0,0,1
58,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.28443724528595815,5.494834710743802,6.908340436043771,['VIP'],0.999266570014494,0,0,1
59,EV release from cardiac cells and their functional effects WP3297,0.28443724528595815,5.494834710743802,6.908340436043771,['ERBB4'],0.999266570014494,0,0,1
60,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.28443724528595815,5.494834710743802,6.908340436043771,['GSS'],0.999266570014494,0,0,1
61,Gastric acid production WP2596,0.28443724528595815,5.494834710743802,6.908340436043771,['VIP'],0.999266570014494,0,0,1
62,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.28443724528595815,5.494834710743802,6.908340436043771,['ELOB'],0.999266570014494,0,0,1
63,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.28443724528595815,5.494834710743802,6.908340436043771,['BLVRB'],0.999266570014494,0,0,1
64,let-7 inhibition of ES cell reprogramming WP3299,0.28443724528595815,5.494834710743802,6.908340436043771,['SOX2'],0.999266570014494,0,0,1
65,"Phase I biotransformations, non P450 WP136",0.28443724528595815,5.494834710743802,6.908340436043771,['CES2'],0.999266570014494,0,0,1
66,Small Ligand GPCRs WP247,0.28443724528595815,5.494834710743802,6.908340436043771,['LPAR1'],0.999266570014494,0,0,1
67,Valproic acid pathway WP3871,0.28443724528595815,5.494834710743802,6.908340436043771,['IVD'],0.999266570014494,0,0,1
68,Pyrimidine metabolism WP4022,0.29137625551792107,1.3337117270519976,1.6446531093069754,"['POLE4', 'POLR3GL', 'POLR1B', 'POLD2', 'ENPP1', 'NME3', 'POLR2I', 'POLR2K']",0.999266570014494,0,0,8
69,Cell Differentiation - Index expanded WP2023,0.2948160255120925,2.198552223371251,2.6853199511266457,"['SOX2', 'LEFTY1']",0.999266570014494,0,0,2
70,Kennedy pathway from sphingolipids WP3933,0.2948160255120925,2.198552223371251,2.6853199511266457,"['CHKA', 'ETNK1']",0.999266570014494,0,0,2
71,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.2948160255120925,2.198552223371251,2.6853199511266457,"['MDH2', 'NAMPT']",0.999266570014494,0,0,2
72,SARS coronavirus and innate immunity WP4912,0.2948160255120925,2.198552223371251,2.6853199511266457,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
73,Wnt Signaling Pathway WP363,0.2970660750471743,1.5709844559585493,1.9068620166484667,"['PRKCG', 'CDK6', 'DVL3', 'ROR2']",0.999266570014494,0,0,4
74,DNA Replication WP466,0.3235353495636319,1.6490683229813665,1.8608860349603715,"['PCNA', 'POLD2', 'UBA52']",0.999266570014494,0,0,3
75,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3235353495636319,1.6490683229813665,1.8608860349603715,"['IFITM3', 'ATF2', 'DDIT3']",0.999266570014494,0,0,3
76,SARS-CoV-2 mitochondrial interactions WP5038,0.3235353495636319,1.6490683229813665,1.8608860349603715,"['NDUFB9', 'IRF3', 'TRAF3']",0.999266570014494,0,0,3
77,Cytosolic DNA-sensing pathway WP4655,0.3344906787823079,1.4659758203799655,1.6054579456236573,"['CYLD', 'IRF3', 'POLR3GL', 'POLR2K']",0.999266570014494,0,0,4
78,MECP2 and Associated Rett Syndrome WP3584,0.3408655816948265,1.3196261682242991,1.4202701869170937,"['RBFOX1', 'BCL6', 'SST', 'RPS6', 'CAMK2A', 'MBP']",0.999266570014494,0,0,6
79,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.35574489762399336,1.8317821440882454,1.8932226536769292,"['B4GALT2', 'B3GALT2']",0.999266570014494,0,0,2
80,miRNA regulation of p53 pathway in prostate cancer WP3982,0.35574489762399336,1.8317821440882454,1.8932226536769292,"['SESN3', 'SHISA5']",0.999266570014494,0,0,2
81,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.35574489762399336,1.8317821440882454,1.8932226536769292,"['LATS1', 'STK3']",0.999266570014494,0,0,2
82,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.35574489762399336,1.8317821440882454,1.8932226536769292,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
83,Non-small cell lung cancer WP4255,0.3719248014312614,1.3087828492392808,1.2944694657987428,"['PRKCG', 'CDK6', 'BAD', 'CYCS', 'E2F3']",0.999266570014494,0,0,5
84,Modulators of TCR signaling and T cell activation WP5072,0.3720924835180173,1.3740932642487047,1.3584462498903778,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.999266570014494,0,0,4
85,Nucleotide Excision Repair WP4753,0.3720924835180173,1.3740932642487047,1.3584462498903778,"['POLE4', 'PCNA', 'POLD2', 'GTF2H5']",0.999266570014494,0,0,4
86,Cell Differentiation - Index WP2029,0.3947250396128288,2.746900826446281,2.5534252255505874,['LEFTY1'],0.999266570014494,0,0,1
87,Estrogen Receptor Pathway WP2881,0.3947250396128288,2.746900826446281,2.5534252255505874,['PPARA'],0.999266570014494,0,0,1
88,Homologous recombination WP186,0.3947250396128288,2.746900826446281,2.5534252255505874,['POLD2'],0.999266570014494,0,0,1
89,NAD+ metabolism WP3644,0.3947250396128288,2.746900826446281,2.5534252255505874,['NAMPT'],0.999266570014494,0,0,1
90,Non-homologous end joining WP438,0.3947250396128288,2.746900826446281,2.5534252255505874,['DCLRE1C'],0.999266570014494,0,0,1
91,Regulation of toll-like receptor signaling pathway WP1449,0.3948251886944578,1.2024428274428274,1.117444756045755,"['OTUD5', 'CYLD', 'CUEDC2', 'IRF3', 'TRAF3', 'SQSTM1', 'RNF41']",0.999266570014494,0,0,7
92,Prader-Willi and Angelman Syndrome WP3998,0.4136121859605248,1.3737060041407867,1.2127440541418937,"['CDK6', 'HTR2C', 'NGF']",0.999266570014494,0,0,3
93,Computational Model of Aerobic Glycolysis WP4629,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['LDHA', 'HK1']",0.999266570014494,0,0,2
94,Cori Cycle WP1946,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['LDHA', 'HK1']",0.999266570014494,0,0,2
95,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['CASP6', 'CYCS']",0.999266570014494,0,0,2
96,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['FGF1', 'GTPBP4']",0.999266570014494,0,0,2
97,miRNA targets in ECM and membrane receptors WP2911,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['ITGB5', 'COL5A1']",0.999266570014494,0,0,2
98,Monoamine Transport WP727,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['UNC13B', 'ACHE']",0.999266570014494,0,0,2
99,Neural Crest Cell Migration during Development WP4564,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['CDH11', 'EPHB3']",0.999266570014494,0,0,2
100,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.4146574506582037,1.5698035160289556,1.3819019905924794,"['OMG', 'MBP']",0.999266570014494,0,0,2
101,Serotonin and anxiety WP3947,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['CRH', 'HTR2C']",0.999266570014494,0,0,2
102,Toll-like Receptor Signaling related to MyD88 WP3858,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
103,Zinc homeostasis WP3529,0.4146574506582037,1.5698035160289556,1.3819019905924794,"['SLC30A3', 'SLC39A11']",0.999266570014494,0,0,2
104,Ciliary landscape WP4352,0.4254296134474697,1.0859015713860065,0.9280720387041328,"['NDUFA5', 'SSNA1', 'CAMK2A', 'COPS7A', 'MYL6B', 'WDR34', 'COX6C', 'LSM4', 'SPATA7', 'MYL6', 'WNK1', 'XPNPEP3', 'TNKS1BP1', 'DVL3', 'SNRPB2', 'DCAF11']",0.999266570014494,0,0,16
105,Acute viral myocarditis WP4298,0.4372473577219045,1.194524625653978,0.988177912237972,"['ENDOG', 'CASP6', 'DAG1', 'CYCS', 'DMD']",0.999266570014494,0,0,5
106,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4372473577219045,1.194524625653978,0.988177912237972,"['PFKFB2', 'ATF2', 'BAD', 'RPS6', 'ZNF516']",0.999266570014494,0,0,5
107,Glycogen Synthesis and Degradation WP500,0.4572920342876526,1.267797419971333,0.9919666242486315,"['PHKG1', 'PHKA2', 'HK1']",0.999266570014494,0,0,3
108,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4572920342876526,1.267797419971333,0.9919666242486315,"['BAD', 'CAMK2A', 'CYCS']",0.999266570014494,0,0,3
109,Fragile X Syndrome  WP4549,0.4694005505073973,1.0773068351428163,0.8147658911874692,"['DEPTOR', 'DUSP3', 'ALDH5A1', 'CAMK4', 'CAMK2A', 'DAG1', 'AP2S1', 'AKAP5', 'DLGAP3', 'AP2M1']",0.999266570014494,0,0,10
110,16p11.2 distal deletion syndrome WP4950,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['RAB4A', 'CD81']",0.999266570014494,0,0,2
111,Cell migration and invasion through p75NTR WP4561,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['EFNB2', 'CDH11']",0.999266570014494,0,0,2
112,GDNF/RET signaling axis WP4830,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['ROBO2', 'FAT4']",0.999266570014494,0,0,2
113,Globo Sphingolipid Metabolism WP1424,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['ST6GAL1', 'ST6GAL2']",0.999266570014494,0,0,2
114,Melatonin metabolism and effects WP3298,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['ACHE', 'CAMK2A']",0.999266570014494,0,0,2
115,MTHFR deficiency WP4288,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['CHKA', 'CYCS']",0.999266570014494,0,0,2
116,Neural Crest Cell Migration in Cancer WP4565,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['CDH11', 'EPHB3']",0.999266570014494,0,0,2
117,TLR4 Signaling and Tolerance WP3851,0.47072873777586555,1.3733195449844882,1.0347595809010595,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
118,Exercise-induced Circadian Regulation WP410,0.48265311897177016,1.1564766839378238,0.842443609218979,"['DAZAP2', 'HSPA8', 'SUMO1', 'GSTP1']",0.999266570014494,0,0,4
119,Glycolysis and Gluconeogenesis WP534,0.48265311897177016,1.1564766839378238,0.842443609218979,"['LDHA', 'MDH2', 'ALDOC', 'HK1']",0.999266570014494,0,0,4
120,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.48265311897177016,1.1564766839378238,0.842443609218979,"['PRKCG', 'IFI27L2', 'PRKCD', 'CAMK2A']",0.999266570014494,0,0,4
121,ACE Inhibitor Pathway WP554,0.4880292825207124,1.830922865013774,1.313467206451206,['ATP6AP2'],0.999266570014494,0,0,1
122,Aspirin and miRNAs WP4707,0.4880292825207124,1.830922865013774,1.313467206451206,['PPARA'],0.999266570014494,0,0,1
123,Autosomal recessive Osteopetrosis pathways WP4788,0.4880292825207124,1.830922865013774,1.313467206451206,['OSTM1'],0.999266570014494,0,0,1
124,Biogenic Amine Synthesis WP550,0.4880292825207124,1.830922865013774,1.313467206451206,['ACHE'],0.999266570014494,0,0,1
125,Caloric restriction and aging WP4191,0.4880292825207124,1.830922865013774,1.313467206451206,['NAMPT'],0.999266570014494,0,0,1
126,"Cerebral organic acidurias, including diseases WP4519",0.4880292825207124,1.830922865013774,1.313467206451206,['MDH2'],0.999266570014494,0,0,1
127,Dopaminergic Neurogenesis WP2855,0.4880292825207124,1.830922865013774,1.313467206451206,['SOX2'],0.999266570014494,0,0,1
128,Dual hijack model of Vif in HIV infection WP3300,0.4880292825207124,1.830922865013774,1.313467206451206,['ELOB'],0.999266570014494,0,0,1
129,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.4880292825207124,1.830922865013774,1.313467206451206,['PPARA'],0.999266570014494,0,0,1
130,Galanin receptor pathway WP4970,0.4880292825207124,1.830922865013774,1.313467206451206,['PRKCD'],0.999266570014494,0,0,1
131,Glial Cell Differentiation WP2276,0.4880292825207124,1.830922865013774,1.313467206451206,['MBP'],0.999266570014494,0,0,1
132,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.4880292825207124,1.830922865013774,1.313467206451206,['SQSTM1'],0.999266570014494,0,0,1
133,Irinotecan pathway WP229,0.4880292825207124,1.830922865013774,1.313467206451206,['CES2'],0.999266570014494,0,0,1
134,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4880292825207124,1.830922865013774,1.313467206451206,['VEGFB'],0.999266570014494,0,0,1
135,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.49952454044201966,1.1770186335403727,0.8169669293189858,"['DEPTOR', 'MAP1LC3A', 'ATG7']",0.999266570014494,0,0,3
136,Photodynamic therapy-induced unfolded protein response WP3613,0.49952454044201966,1.1770186335403727,0.8169669293189858,"['DDIT3', 'DNAJB9', 'PDIA6']",0.999266570014494,0,0,3
137,Apoptosis Modulation and Signaling WP1772,0.5009043506376393,1.0985477178423237,0.7594701034056598,"['ENDOG', 'CASP6', 'TRAF3', 'BAD', 'CYCS']",0.999266570014494,0,0,5
138,ErbB signaling pathway WP673,0.5009043506376393,1.0985477178423237,0.7594701034056598,"['PRKCG', 'BTC', 'ERBB4', 'BAD', 'CAMK2A']",0.999266570014494,0,0,5
139,IL-18 signaling pathway WP4754,0.5025542011638992,1.0348523437026256,0.7120319990393117,"['TOMM40', 'PHF20', 'CD81', 'BAD', 'TSHZ1', 'PRKCD', 'NDUFC1', 'RND2', 'LARS2', 'GRM7', 'NACA', 'TMSB4X', 'CYCS']",0.999266570014494,0,0,13
140,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5170110457591455,1.0086442220200182,0.6653935554081033,"['ATF2', 'RPL5', 'SET', 'ITGB5', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'DNAJB9', 'WASF1', 'CCT7', 'RAB4A', 'TRPC3', 'PRKCD', 'RPS6', 'PDIA6', 'INPP4B', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'EIF3D', 'PTMA']",0.999266570014494,0,0,27
141,Neural Crest Differentiation WP2064,0.5178617207996642,1.0984455958549222,0.7228288516686562,"['LHX2', 'DVL3', 'MBP', 'HDAC8']",0.999266570014494,0,0,4
142,Autophagy WP4923,0.5234354073041081,1.220498678616569,0.7900796193125869,"['DEPTOR', 'ATG7']",0.999266570014494,0,0,2
143,Fluoropyrimidine Activity WP1601,0.5234354073041081,1.220498678616569,0.7900796193125869,"['TDG', 'CES2']",0.999266570014494,0,0,2
144,Trans-sulfuration and one-carbon metabolism WP2525,0.5234354073041081,1.220498678616569,0.7900796193125869,"['DHFR2', 'GSS']",0.999266570014494,0,0,2
145,ATM Signaling Network in Development and Disease  WP3878,0.5400162104949441,1.098343685300207,0.6767511840435895,"['ATF2', 'DCLRE1C', 'TRIM28']",0.999266570014494,0,0,3
146,GABA receptor Signaling WP4159,0.5400162104949441,1.098343685300207,0.6767511840435895,"['SLC32A1', 'AP2S1', 'AP2M1']",0.999266570014494,0,0,3
147,IL-6 signaling pathway WP364,0.5400162104949441,1.098343685300207,0.6767511840435895,"['BAD', 'PRKCD', 'VIP']",0.999266570014494,0,0,3
148,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5400162104949441,1.098343685300207,0.6767511840435895,"['ATF2', 'CAMK4', 'CAMK2A']",0.999266570014494,0,0,3
149,Ectoderm Differentiation WP2858,0.5469857392536822,1.0084821428571429,0.6084501005944706,"['SOX2', 'GREB1', 'ARHGDIG', 'PIM1', 'DMD', 'ROR2', 'NR2F2', 'NF2', 'MZF1']",0.999266570014494,0,0,9
150,Eukaryotic Transcription Initiation WP405,0.5519021869563644,1.0459412780656303,0.621691227058437,"['TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.999266570014494,0,0,4
151,Metabolic reprogramming in colon cancer WP4290,0.5519021869563644,1.0459412780656303,0.621691227058437,"['LDHA', 'MDH2', 'GLS', 'IDH3A']",0.999266570014494,0,0,4
152,Alzheimer's disease WP2059,0.5615739122857514,1.0167896111879515,0.5866996849453324,"['ATP5MD', 'APH1A', 'BAD', 'CHP1', 'CYCS']",0.999266570014494,0,0,5
153,Disorders of the Krebs cycle WP4236,0.5669630310909203,1.3729338842975207,0.7790866796811303,['DHTKD1'],0.999266570014494,0,0,1
154,Genes targeted by miRNAs in adipocytes WP1992,0.5669630310909203,1.3729338842975207,0.7790866796811303,['TMSB4X'],0.999266570014494,0,0,1
155,Hedgehog Signaling Pathway Netpath WP47,0.5669630310909203,1.3729338842975207,0.7790866796811303,['KIF7'],0.999266570014494,0,0,1
156,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5669630310909203,1.3729338842975207,0.7790866796811303,['RPS6'],0.999266570014494,0,0,1
157,Insulin signaling in adipocytes (normal condition) WP3634,0.5669630310909203,1.3729338842975207,0.7790866796811303,['RPS6'],0.999266570014494,0,0,1
158,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5669630310909203,1.3729338842975207,0.7790866796811303,['ERBB4'],0.999266570014494,0,0,1
159,Matrix Metalloproteinases WP129,0.5669630310909203,1.3729338842975207,0.7790866796811303,['MMP16'],0.999266570014494,0,0,1
160,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5669630310909203,1.3729338842975207,0.7790866796811303,['COL5A1'],0.999266570014494,0,0,1
161,Mitochondrial fatty acid synthesis pathway WP4317,0.5669630310909203,1.3729338842975207,0.7790866796811303,['HSD17B12'],0.999266570014494,0,0,1
162,"NAD metabolism, sirtuins and aging WP3630",0.5669630310909203,1.3729338842975207,0.7790866796811303,['NAMPT'],0.999266570014494,0,0,1
163,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5669630310909203,1.3729338842975207,0.7790866796811303,['IRF3'],0.999266570014494,0,0,1
164,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5669630310909203,1.3729338842975207,0.7790866796811303,['IRF3'],0.999266570014494,0,0,1
165,Transcriptional cascade regulating adipogenesis WP4211,0.5669630310909203,1.3729338842975207,0.7790866796811303,['DDIT3'],0.999266570014494,0,0,1
166,Pathways Regulating Hippo Signaling WP4540,0.569914427388196,0.998206362692344,0.5612605500556754,"['PRKCG', 'LATS1', 'PRKCD', 'CDH11', 'NF2', 'STK3']",0.999266570014494,0,0,6
167,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5724824937191291,1.0982419855222336,0.6125698617206278,"['LDHA', 'RPS6']",0.999266570014494,0,0,2
168,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5724824937191291,1.0982419855222336,0.6125698617206278,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
169,Notch Signaling WP268,0.5724824937191291,1.0982419855222336,0.6125698617206278,"['APH1A', 'DVL3']",0.999266570014494,0,0,2
170,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5724824937191291,1.0982419855222336,0.6125698617206278,"['NDUFA13', 'AAMP']",0.999266570014494,0,0,2
171,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5724824937191291,1.0982419855222336,0.6125698617206278,"['PRKCG', 'TRPC3']",0.999266570014494,0,0,2
172,Pre-implantation embryo WP3527,0.5724824937191291,1.0982419855222336,0.6125698617206278,"['SOX2', 'DDIT3']",0.999266570014494,0,0,2
173,Common Pathways Underlying Drug Addiction WP2636,0.5785522225153731,1.029503105590062,0.5633713442935024,"['PRKCG', 'CAMK4', 'CAMK2A']",0.999266570014494,0,0,3
174,Development of ureteric collection system WP5053,0.5785522225153731,1.029503105590062,0.5633713442935024,"['ROBO2', 'GDF11', 'FAT4']",0.999266570014494,0,0,3
175,Mesodermal commitment pathway WP2857,0.601365530960554,0.9604989604989606,0.4884639792674079,"['SOX2', 'LATS1', 'LEFTY1', 'ARL4A', 'TRIM28', 'RPL38', 'ACVR2A']",0.999266570014494,0,0,7
176,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6064355732647304,0.9544405736777813,0.4773699272189838,"['BAD', 'CAMK4', 'RPS6', 'PRKCD', 'CAMK2A', 'NGF', 'SQSTM1', 'EIF2S1']",0.999266570014494,0,0,8
177,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6149862670986749,0.9687614176105225,0.4709685376610744,"['DEPTOR', 'MAP1LC3A', 'IGFBP5']",0.999266570014494,0,0,3
178,Regulation of Microtubule Cytoskeleton WP2038,0.6149862670986749,0.9687614176105225,0.4709685376610744,"['PARD6A', 'CAMK4', 'MAPRE1']",0.999266570014494,0,0,3
179,Wnt signaling pathway and pluripotency WP399,0.6159170869368722,0.954629421040775,0.46265439360247457,"['SOX2', 'PRKCG', 'PRKCD', 'DVL3']",0.999266570014494,0,0,4
180,Allograft Rejection WP2328,0.6177455756723762,0.998213782081414,0.4808182132030737,"['COL5A1', 'HLA-B']",0.999266570014494,0,0,2
181,Amyotrophic lateral sclerosis (ALS) WP2447,0.6177455756723762,0.998213782081414,0.4808182132030737,"['TOMM40', 'BAD']",0.999266570014494,0,0,2
182,Cardiac Progenitor Differentiation WP2406,0.6177455756723762,0.998213782081414,0.4808182132030737,"['SOX2', 'ROR2']",0.999266570014494,0,0,2
183,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6177455756723762,0.998213782081414,0.4808182132030737,"['RAB4A', 'RABAC1']",0.999266570014494,0,0,2
184,Netrin-UNC5B signaling pathway WP4747,0.6177455756723762,0.998213782081414,0.4808182132030737,"['DAPK1', 'PLEKHH1']",0.999266570014494,0,0,2
185,The influence of laminopathies on Wnt signaling WP4844,0.6177455756723762,0.998213782081414,0.4808182132030737,"['CDK6', 'ZMPSTE24']",0.999266570014494,0,0,2
186,MAPK Signaling Pathway WP382,0.624710580649352,0.9404388714733543,0.44244527347075935,"['PRKCG', 'DUSP4', 'ATF2', 'HSPA8', 'DUSP3', 'DDIT3', 'RASGRF2', 'PRKCD', 'FGF1', 'RASGRP2', 'NGF', 'STK3']",0.999266570014494,0,0,12
187,mRNA Processing WP411,0.6316643810150999,0.9316627358490566,0.42800312975988686,"['LSM7', 'SF3A1', 'CELF1', 'HNRNPA2B1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'SRSF9']",0.999266570014494,0,0,9
188,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6337376564748094,1.0981404958677685,0.5008840639531928,['RPH3AL'],0.999266570014494,0,0,1
189,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6337376564748094,1.0981404958677685,0.5008840639531928,['ENPP1'],0.999266570014494,0,0,1
190,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6337376564748094,1.0981404958677685,0.5008840639531928,['GRM7'],0.999266570014494,0,0,1
191,Heart Development WP1591,0.6337376564748094,1.0981404958677685,0.5008840639531928,['VEGFB'],0.999266570014494,0,0,1
192,HIF1A and PPARG regulation of glycolysis WP2456,0.6337376564748094,1.0981404958677685,0.5008840639531928,['LDHA'],0.999266570014494,0,0,1
193,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6337376564748094,1.0981404958677685,0.5008840639531928,['ERBB4'],0.999266570014494,0,0,1
194,NAD+ biosynthetic pathways WP3645,0.6337376564748094,1.0981404958677685,0.5008840639531928,['NAMPT'],0.999266570014494,0,0,1
195,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6337376564748094,1.0981404958677685,0.5008840639531928,['LDHA'],0.999266570014494,0,0,1
196,PPAR-alpha pathway WP2878,0.6337376564748094,1.0981404958677685,0.5008840639531928,['PPARA'],0.999266570014494,0,0,1
197,Purinergic signaling WP4900,0.6337376564748094,1.0981404958677685,0.5008840639531928,['PANX1'],0.999266570014494,0,0,1
198,16p11.2 proximal deletion syndrome WP4949,0.6449610683880279,0.9145919778699861,0.4011083262759045,"['UNC13B', 'PCNA', 'TMEM219', 'SEZ6L2', 'CCT7']",0.999266570014494,0,0,5
199,Retinoblastoma gene in cancer WP2446,0.6456953514704595,0.9146804835924007,0.4001063776488037,"['PCNA', 'CDK6', 'E2F3', 'SAP30']",0.999266570014494,0,0,4
200,Myometrial relaxation and contraction pathways WP289,0.653935477465705,0.9141466805700382,0.38828068597304227,"['PRKCG', 'ATF2', 'RGS17', 'IGFBP5', 'GRK4', 'GSTO1', 'PRKCD', 'CAMK2A', 'LPAR1', 'CRH']",0.999266570014494,0,0,10
201,Complement system WP2806,0.6592253096237751,0.9148569458807307,0.38121165539579144,"['RPS19', 'CD59']",0.999266570014494,0,0,2
202,Differentiation Pathway WP2848,0.6592253096237751,0.9148569458807307,0.38121165539579144,"['LEFTY1', 'FGF1']",0.999266570014494,0,0,2
203,Ethanol effects on histone modifications WP3996,0.6592253096237751,0.9148569458807307,0.38121165539579144,"['ATF2', 'HDAC8']",0.999266570014494,0,0,2
204,Monoamine GPCRs WP58,0.6592253096237751,0.9148569458807307,0.38121165539579144,"['HTR2C', 'HTR5A']",0.999266570014494,0,0,2
205,Nuclear receptors WP170,0.6592253096237751,0.9148569458807307,0.38121165539579144,"['NR2F2', 'PPARA']",0.999266570014494,0,0,2
206,Unfolded protein response WP4925,0.6592253096237751,0.9148569458807307,0.38121165539579144,"['DDIT3', 'EIF2S1']",0.999266570014494,0,0,2
207,Senescence and Autophagy in Cancer WP615,0.6690334348884176,0.8896185905531699,0.35755660943619255,"['GABARAPL1', 'MAP1LC3A', 'PCNA', 'IGFBP5', 'SQSTM1', 'ATG7']",0.999266570014494,0,0,6
208,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6812463740647536,0.8664596273291926,0.3325742865914176,"['PRKCD', 'RPS6', 'PIM1']",0.999266570014494,0,0,3
209,Integrated breast cancer pathway WP1984,0.6897301029210496,0.8725193725193725,0.3241016076962569,"['FER', 'BAD', 'DCAKD', 'ODC1', 'DAG1', 'FAU', 'DHTKD1']",0.999266570014494,0,0,7
210,Biomarkers for pyrimidine metabolism disorders WP4584,0.6902245363706351,0.9149449035812672,0.3392051358029953,['PUS1'],0.999266570014494,0,0,1
211,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6902245363706351,0.9149449035812672,0.3392051358029953,['SST'],0.999266570014494,0,0,1
212,Cysteine and methionine catabolism WP4504,0.6902245363706351,0.9149449035812672,0.3392051358029953,['GSS'],0.999266570014494,0,0,1
213,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6902245363706351,0.9149449035812672,0.3392051358029953,['CD81'],0.999266570014494,0,0,1
214,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6902245363706351,0.9149449035812672,0.3392051358029953,['BAD'],0.999266570014494,0,0,1
215,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6902245363706351,0.9149449035812672,0.3392051358029953,['EIF2AK1'],0.999266570014494,0,0,1
216,miRNAs involved in DNA damage response WP1545,0.6902245363706351,0.9149449035812672,0.3392051358029953,['CDK6'],0.999266570014494,0,0,1
217,miRNAs involvement in the immune response in sepsis WP4329,0.6902245363706351,0.9149449035812672,0.3392051358029953,['TRAF3'],0.999266570014494,0,0,1
218,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6902245363706351,0.9149449035812672,0.3392051358029953,['PPARA'],0.999266570014494,0,0,1
219,Signal Transduction of S1P Receptor WP26,0.6902245363706351,0.9149449035812672,0.3392051358029953,['ASAH1'],0.999266570014494,0,0,1
220,Tryptophan catabolism leading to NAD+ production WP4210,0.6902245363706351,0.9149449035812672,0.3392051358029953,['NAMPT'],0.999266570014494,0,0,1
221,Urea cycle and associated pathways WP4595,0.6902245363706351,0.9149449035812672,0.3392051358029953,['MDH2'],0.999266570014494,0,0,1
222,Urea cycle and metabolism of amino groups WP497,0.6902245363706351,0.9149449035812672,0.3392051358029953,['ODC1'],0.999266570014494,0,0,1
223,Wnt signaling in kidney disease WP4150,0.6902245363706351,0.9149449035812672,0.3392051358029953,['DVL3'],0.999266570014494,0,0,1
224,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.697011905011429,0.8443242383263065,0.30476118780555655,"['PRKCG', 'PRKCD']",0.999266570014494,0,0,2
225,Type 2 papillary renal cell carcinoma WP4241,0.697011905011429,0.8443242383263065,0.30476118780555655,"['COL21A1', 'ELOB']",0.999266570014494,0,0,2
226,Corticotropin-releasing hormone signaling pathway WP2355,0.7005222545021443,0.8440015942606616,0.3004047651961165,"['TRIM28', 'PRKCD', 'CAMK2A', 'CRH']",0.999266570014494,0,0,4
227,Melanoma WP4685,0.7005222545021443,0.8440015942606616,0.3004047651961165,"['CDK6', 'ERBB4', 'BAD', 'E2F3']",0.999266570014494,0,0,4
228,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7255357439464696,0.8125887545576664,0.26071499008236415,"['PRKCG', 'BAD', 'RPS6', 'PDGFC']",0.999266570014494,0,0,4
229,EGF/EGFR signaling pathway WP437,0.7288388920041761,0.8342673777456386,0.2638809156646268,"['NDUFA13', 'PCNA', 'PRKCD', 'CAMK2A', 'AP2S1', 'NEDD8', 'AP2M1']",0.999266570014494,0,0,7
230,p38 MAPK Signaling Pathway WP400,0.7312575603986388,0.7838676318510859,0.2453423706763051,"['ATF2', 'DDIT3']",0.999266570014494,0,0,2
231,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7312575603986388,0.7838676318510859,0.2453423706763051,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
232,Differentiation of white and brown adipocyte WP2895,0.7380072822582039,0.7840909090909091,0.23820806243357573,['PPARGC1B'],0.999266570014494,0,0,1
233,Sleep regulation WP3591,0.7380072822582039,0.7840909090909091,0.23820806243357573,['CRH'],0.999266570014494,0,0,1
234,AGE/RAGE pathway WP2324,0.7386315290397591,0.7836438923395446,0.23740968950034605,"['ATF2', 'PRKCD', 'CYCS']",0.999266570014494,0,0,3
235,G1 to S cell cycle control WP45,0.7386315290397591,0.7836438923395446,0.23740968950034605,"['PCNA', 'CDK6', 'E2F3']",0.999266570014494,0,0,3
236,Ebola Virus Pathway on Host WP4217,0.7393731937295325,0.8063827190627288,0.24348926767368975,"['IRF3', 'HLA-B', 'DAB2IP', 'MERTK', 'EIF2S1']",0.999266570014494,0,0,5
237,Small cell lung cancer WP4658,0.7489588354977755,0.783419689119171,0.22646411371033745,"['CDK6', 'TRAF3', 'CYCS', 'E2F3']",0.999266570014494,0,0,4
238,Hippo-Merlin Signaling Dysregulation WP4541,0.7598476638393782,0.783195020746888,0.21509457222277853,"['LATS1', 'ITGB5', 'CDH11', 'NF2', 'STK3']",0.999266570014494,0,0,5
239,Pathways in clear cell renal cell carcinoma WP4018,0.7598476638393782,0.783195020746888,0.21509457222277853,"['LDHA', 'DEPTOR', 'ALDOC', 'SQSTM1', 'HK1']",0.999266570014494,0,0,5
240,Copper homeostasis WP3286,0.7621552548831306,0.7314719062392279,0.19867142525314807,"['COMMD1', 'ATOX1']",0.999266570014494,0,0,2
241,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7640945881344187,0.7478825522303784,0.20122803995281818,"['PCNA', 'DAG1', 'TLN1']",0.999266570014494,0,0,3
242,Wnt signaling WP428,0.7708188176867192,0.756262283366089,0.19685653160615374,"['PRKCG', 'CAMK2A', 'DVL3', 'ROR2']",0.999266570014494,0,0,4
243,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7784259507653996,0.6859504132231405,0.17181782674026974,['RPS6'],0.999266570014494,0,0,1
244,IL-7 signaling pathway WP205,0.7784259507653996,0.6859504132231405,0.17181782674026974,['BAD'],0.999266570014494,0,0,1
245,Immune response to tuberculosis WP4197,0.7784259507653996,0.6859504132231405,0.17181782674026974,['PTPN2'],0.999266570014494,0,0,1
246,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7784259507653996,0.6859504132231405,0.17181782674026974,['GSTP1'],0.999266570014494,0,0,1
247,Pregnane X receptor pathway WP2876,0.7784259507653996,0.6859504132231405,0.17181782674026974,['PSMC5'],0.999266570014494,0,0,1
248,Prostaglandin Synthesis and Regulation WP98,0.7784259507653996,0.6859504132231405,0.17181782674026974,['PPARGC1B'],0.999266570014494,0,0,1
249,Sphingolipid Metabolism (general overview) WP4725,0.7784259507653996,0.6859504132231405,0.17181782674026974,['ASAH1'],0.999266570014494,0,0,1
250,Sphingolipid Metabolism (integrated pathway) WP4726,0.7784259507653996,0.6859504132231405,0.17181782674026974,['ASAH1'],0.999266570014494,0,0,1
251,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.7784259507653996,0.6859504132231405,0.17181782674026974,['PPARA'],0.999266570014494,0,0,1
252,Striated Muscle Contraction Pathway WP383,0.7784259507653996,0.6859504132231405,0.17181782674026974,['DMD'],0.999266570014494,0,0,1
253,Hepatitis B infection WP4666,0.7808780971666611,0.7827442827442828,0.19360101752083628,"['PRKCG', 'ATF2', 'PCNA', 'IRF3', 'TRAF3', 'BAD', 'CYCS']",0.999266570014494,0,0,7
254,3q29 copy number variation syndrome WP4906,0.7875035885564627,0.7152308938698353,0.17085961387289816,"['SENP5', 'NF2', 'WDR34']",0.999266570014494,0,0,3
255,Genotoxicity pathway WP4286,0.7899225930723554,0.6856256463288521,0.16168446053410349,"['RPS27', 'PHLDA3']",0.999266570014494,0,0,2
256,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7911556558407328,0.730915371329879,0.17122463466718915,"['HSPA8', 'PSMC5', 'PSMC1', 'UBE2J1']",0.999266570014494,0,0,4
257,Thermogenesis WP4321,0.8100194446979945,0.7072037439411666,0.14900572548571173,"['ATF2', 'RPS6', 'ZNF516', 'CPT1B']",0.999266570014494,0,0,4
258,Alpha 6 Beta 4 signaling pathway WP244,0.8126144691081714,0.6096189164370982,0.12649500441996386,['PRKCD'],0.999266570014494,0,0,1
259,FOXA2 pathway WP5066,0.8126144691081714,0.6096189164370982,0.12649500441996386,['PPARGC1B'],0.999266570014494,0,0,1
260,Gastric Cancer Network 1 WP2361,0.8126144691081714,0.6096189164370982,0.12649500441996386,['SMOC2'],0.999266570014494,0,0,1
261,Hedgehog Signaling Pathway WP4249,0.8126144691081714,0.6096189164370982,0.12649500441996386,['KIF7'],0.999266570014494,0,0,1
262,Imatinib and Chronic Myeloid Leukemia WP3640,0.8126144691081714,0.6096189164370982,0.12649500441996386,['PIM1'],0.999266570014494,0,0,1
263,NOTCH1 regulation of endothelial cell calcification WP3413,0.8126144691081714,0.6096189164370982,0.12649500441996386,['LPAR1'],0.999266570014494,0,0,1
264,Oxidation by Cytochrome P450 WP43,0.8126144691081714,0.6096189164370982,0.12649500441996386,['CYP4Z1'],0.999266570014494,0,0,1
265,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8126144691081714,0.6096189164370982,0.12649500441996386,['HTR2C'],0.999266570014494,0,0,1
266,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8126144691081714,0.6096189164370982,0.12649500441996386,['RPS6'],0.999266570014494,0,0,1
267,TP53 network WP1742,0.8126144691081714,0.6096189164370982,0.12649500441996386,['SUMO1'],0.999266570014494,0,0,1
268,IL-4 signaling pathway WP395,0.814789652509129,0.6451730640549912,0.13214776261263303,"['ATF2', 'BAD']",0.999266570014494,0,0,2
269,Kit receptor signaling pathway WP304,0.814789652509129,0.6451730640549912,0.13214776261263303,"['BAD', 'RPS6']",0.999266570014494,0,0,2
270,Nephrotic syndrome WP4758,0.814789652509129,0.6451730640549912,0.13214776261263303,"['E2F3', 'ZMPSTE24']",0.999266570014494,0,0,2
271,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.814789652509129,0.6451730640549912,0.13214776261263303,"['LDHA', 'HK1']",0.999266570014494,0,0,2
272,PPAR signaling pathway WP3942,0.814789652509129,0.6451730640549912,0.13214776261263303,"['PPARA', 'CPT1B']",0.999266570014494,0,0,2
273,Pancreatic adenocarcinoma pathway WP4263,0.8274681250676931,0.6849740932642487,0.12972360770033306,"['CDK6', 'BAD', 'PRKCD', 'E2F3']",0.999266570014494,0,0,4
274,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8285426143243457,0.6577639751552795,0.12371685800654578,"['ITGB5', 'DAG1', 'DMD']",0.999266570014494,0,0,3
275,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8285426143243457,0.6577639751552795,0.12371685800654578,"['CDK6', 'DVL3', 'ROR2']",0.999266570014494,0,0,3
276,Notch Signaling Pathway Netpath WP61,0.8369899853078615,0.6092152131448926,0.10840568840125743,"['APH1A', 'SAP30']",0.999266570014494,0,0,2
277,BDNF-TrkB Signaling WP3676,0.8415323142361917,0.5485537190082644,0.09464244782188187,['TRPC3'],0.999266570014494,0,0,1
278,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.8415323142361917,0.5485537190082644,0.09464244782188187,['BCL6'],0.999266570014494,0,0,1
279,Glycerolipids and Glycerophospholipids WP4722,0.8415323142361917,0.5485537190082644,0.09464244782188187,['ETNK1'],0.999266570014494,0,0,1
280,Glycerophospholipid Biosynthetic Pathway WP2533,0.8415323142361917,0.5485537190082644,0.09464244782188187,['PIP5K1A'],0.999266570014494,0,0,1
281,Glycosylation and related congenital defects WP4521,0.8415323142361917,0.5485537190082644,0.09464244782188187,['MAGT1'],0.999266570014494,0,0,1
282,IL17 signaling pathway WP2112,0.8415323142361917,0.5485537190082644,0.09464244782188187,['TRAF3'],0.999266570014494,0,0,1
283,Methionine De Novo and Salvage Pathway WP3580,0.8415323142361917,0.5485537190082644,0.09464244782188187,['ODC1'],0.999266570014494,0,0,1
284,Nanoparticle-mediated activation of receptor signaling WP2643,0.8415323142361917,0.5485537190082644,0.09464244782188187,['TLN1'],0.999266570014494,0,0,1
285,Phosphoinositides metabolism WP4971,0.8415323142361917,0.5485537190082644,0.09464244782188187,['PIP5K1A'],0.999266570014494,0,0,1
286,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8415323142361917,0.5485537190082644,0.09464244782188187,['BAD'],0.999266570014494,0,0,1
287,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8415323142361917,0.5485537190082644,0.09464244782188187,['TRAF3'],0.999266570014494,0,0,1
288,Tryptophan metabolism WP465,0.8415323142361917,0.5485537190082644,0.09464244782188187,['OGDH'],0.999266570014494,0,0,1
289,G Protein Signaling Pathways WP35,0.843565462998455,0.6640916941435077,0.11297379890428579,"['PRKCG', 'PRKCD', 'AKAP5', 'PDE7B']",0.999266570014494,0,0,4
290,Adipogenesis WP236,0.8443023179506549,0.6846473029045643,0.11587289445386159,"['CELF1', 'DDIT3', 'NAMPT', 'PPARA', 'ZMPSTE24']",0.999266570014494,0,0,5
291,Calcium Regulation in the Cardiac Cell WP536,0.8546418861443229,0.7176950239675202,0.11273032705748255,"['PRKCG', 'SLC8A3', 'RGS17', 'GRK4', 'CAMK4', 'PRKCD', 'CAMK2A', 'ATP1B2']",0.999266570014494,0,0,8
292,Proximal tubule transport WP4917,0.8567540919041619,0.5770423991726991,0.08921326052344657,"['SLC13A3', 'ATP6V1F']",0.999266570014494,0,0,2
293,RANKL/RANK signaling pathway WP2018,0.8567540919041619,0.5770423991726991,0.08921326052344657,"['TRAF3', 'SQSTM1']",0.999266570014494,0,0,2
294,Rett syndrome causing genes WP4312,0.8567540919041619,0.5770423991726991,0.08921326052344657,"['GPS2', 'HDAC8']",0.999266570014494,0,0,2
295,NRF2 pathway WP2884,0.8578685485528056,0.6678220827851432,0.1023800624035026,"['GSTP1', 'SLC39A11', 'BLVRB', 'SQSTM1', 'CES2']",0.999266570014494,0,0,5
296,Regulation of Actin Cytoskeleton WP51,0.8578685485528056,0.6678220827851432,0.1023800624035026,"['TMSB4X', 'PIP5K1A', 'BRK1', 'FGF1', 'WASF1']",0.999266570014494,0,0,5
297,"GPCRs, Class A Rhodopsin-like WP455",0.8583792841291352,0.6444376714416337,0.09841157483892829,"['MC1R', 'HTR2C', 'HTR5A', 'MCHR1']",0.999266570014494,0,0,4
298,Head and Neck Squamous Cell Carcinoma WP4674,0.862592160616051,0.6088106740280653,0.08999030439070821,"['CDK6', 'TRAF3', 'RPS6']",0.999266570014494,0,0,3
299,7-oxo-C and 7beta-HC pathways WP5064,0.8659913278131102,0.49859128474830955,0.071737505779108,['EPHX2'],0.999266570014494,0,0,1
300,Fatty acid beta-oxidation WP143,0.8659913278131102,0.49859128474830955,0.071737505779108,['CPT1B'],0.999266570014494,0,0,1
301,IL-2 signaling pathway WP49,0.8659913278131102,0.49859128474830955,0.071737505779108,['RPS6'],0.999266570014494,0,0,1
302,Sphingolipid pathway WP1422,0.8659913278131102,0.49859128474830955,0.071737505779108,['ASAH1'],0.999266570014494,0,0,1
303,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8743048200601823,0.5480868665977249,0.07362242592835062,"['ERBB4', 'TMSB4X']",0.999266570014494,0,0,2
304,DNA damage response WP707,0.8743048200601823,0.5480868665977249,0.07362242592835062,"['CDK6', 'CYCS']",0.999266570014494,0,0,2
305,IL-1 signaling pathway WP195,0.8743048200601823,0.5480868665977249,0.07362242592835062,"['ATF2', 'SQSTM1']",0.999266570014494,0,0,2
306,MET in type 1 papillary renal cell carcinoma WP4205,0.8743048200601823,0.5480868665977249,0.07362242592835062,"['BAD', 'RPL11']",0.999266570014494,0,0,2
307,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8743048200601823,0.5480868665977249,0.07362242592835062,"['BAD', 'ANGPTL1']",0.999266570014494,0,0,2
308,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8743048200601823,0.5480868665977249,0.07362242592835062,"['ATF2', 'MBP']",0.999266570014494,0,0,2
309,DNA IR-damage and cellular response via ATR WP4016,0.8772767415390252,0.5869565217391305,0.07685185007564116,"['PCNA', 'TRIM28', 'BCL6']",0.999266570014494,0,0,3
310,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8810179317060118,0.7286659700452804,0.09230543728191293,"['PFKFB2', 'ATF2', 'COL5A1', 'ITGB5', 'PIK3IP1', 'BAD', 'PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.999266570014494,0,0,12
311,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8866784132598918,0.4569559228650138,0.05495942220598794,['IRF3'],0.999266570014494,0,0,1
312,Folate Metabolism WP176,0.8866784132598918,0.4569559228650138,0.05495942220598794,['GPX4'],0.999266570014494,0,0,1
313,Gastric Cancer Network 2 WP2363,0.8866784132598918,0.4569559228650138,0.05495942220598794,['OTUD5'],0.999266570014494,0,0,1
314,Genes controlling nephrogenesis WP4823,0.8866784132598918,0.4569559228650138,0.05495942220598794,['ROBO2'],0.999266570014494,0,0,1
315,Intraflagellar transport proteins binding to dynein WP4532,0.8866784132598918,0.4569559228650138,0.05495942220598794,['WDR34'],0.999266570014494,0,0,1
316,miRNA regulation of prostate cancer signaling pathways WP3981,0.8866784132598918,0.4569559228650138,0.05495942220598794,['BAD'],0.999266570014494,0,0,1
317,Peptide GPCRs WP24,0.8866784132598918,0.4569559228650138,0.05495942220598794,['MC1R'],0.999266570014494,0,0,1
318,Tumor suppressor activity of SMARCB1 WP4204,0.8866784132598918,0.4569559228650138,0.05495942220598794,['CDK6'],0.999266570014494,0,0,1
319,miRNA regulation of DNA damage response WP1530,0.8898542516754555,0.5218890037917959,0.06090318994445915,"['CDK6', 'CYCS']",0.999266570014494,0,0,2
320,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8898542516754555,0.5218890037917959,0.06090318994445915,"['DVL3', 'ROR2']",0.999266570014494,0,0,2
321,Glioblastoma signaling pathways WP2261,0.890550972678645,0.5666095523666738,0.06567851077897387,"['PRKCG', 'CDK6', 'PRKCD']",0.999266570014494,0,0,3
322,Ciliopathies WP4803,0.9018873066627118,0.6626935326206919,0.06843351411992495,"['XPNPEP3', 'CEP120', 'ALMS1', 'CEP83', 'PKD1L1', 'KIF7', 'WDR34', 'SPATA7']",0.999266570014494,0,0,8
323,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9036017286364465,0.49807276487731506,0.050487933431772214,"['RNF7', 'SQSTM1']",0.999266570014494,0,0,2
324,Endometrial cancer WP4155,0.9036017286364465,0.49807276487731506,0.050487933431772214,"['BAD', 'FGF1']",0.999266570014494,0,0,2
325,Bladder cancer WP2828,0.904174745870211,0.4217260012714558,0.04248157106796222,['DAPK1'],0.999266570014494,0,0,1
326,IL-5 signaling pathway WP127,0.904174745870211,0.4217260012714558,0.04248157106796222,['RPS6'],0.999266570014494,0,0,1
327,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.904174745870211,0.4217260012714558,0.04248157106796222,['HDAC8'],0.999266570014494,0,0,1
328,Integrated Cancer Pathway WP1971,0.904174745870211,0.4217260012714558,0.04248157106796222,['BAD'],0.999266570014494,0,0,1
329,Lung fibrosis WP3624,0.904174745870211,0.4217260012714558,0.04248157106796222,['FGF1'],0.999266570014494,0,0,1
330,MAPK Cascade WP422,0.904174745870211,0.4217260012714558,0.04248157106796222,['MBP'],0.999266570014494,0,0,1
331,Oxysterols derived from cholesterol WP4545,0.904174745870211,0.4217260012714558,0.04248157106796222,['EPHX2'],0.999266570014494,0,0,1
332,Splicing factor NOVA regulated synaptic proteins WP4148,0.904174745870211,0.4217260012714558,0.04248157106796222,['NTNG1'],0.999266570014494,0,0,1
333,Vitamin D-sensitive calcium signaling in depression WP4698,0.904174745870211,0.4217260012714558,0.04248157106796222,['GPX4'],0.999266570014494,0,0,1
334,Spinal Cord Injury WP2431,0.9133017150156302,0.529853736726107,0.04805189888738618,"['EFNB2', 'OMG', 'MBP']",0.999266570014494,0,0,3
335,Breast cancer pathway WP4262,0.9156801478053544,0.5612860369337054,0.04944265361280453,"['CDK6', 'DVL3', 'E2F3', 'FGF1']",0.999266570014494,0,0,4
336,Gastrin signaling pathway WP4659,0.9156801478053544,0.5612860369337054,0.04944265361280453,"['ATF2', 'BAD', 'RPS6', 'PRKCD']",0.999266570014494,0,0,4
337,Vitamin D Receptor Pathway WP2877,0.9156801478053544,0.5612860369337054,0.04944265361280453,"['IGFBP5', 'BCL6', 'CLEC16A', 'CLPTM1L']",0.999266570014494,0,0,4
338,ATM Signaling Pathway WP2516,0.9189720325452563,0.3915289256198347,0.03308403352187001,['ATF2'],0.999266570014494,0,0,1
339,Interleukin-11 Signaling Pathway WP2332,0.9189720325452563,0.3915289256198347,0.03308403352187001,['RPS6'],0.999266570014494,0,0,1
340,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9199927293223135,0.5819060651540566,0.048524862733678474,"['SOX2', 'SST', 'NGF', 'SLC25A4', 'PPARGC1B']",0.999266570014494,0,0,5
341,T-cell receptor (TCR) signaling pathway WP69,0.9264184617651957,0.45639434677697344,0.03488187482566733,"['ATF2', 'PRKCD']",0.999266570014494,0,0,2
342,Toll-like Receptor Signaling Pathway WP75,0.9264184617651957,0.45639434677697344,0.03488187482566733,"['IRF3', 'TRAF3']",0.999266570014494,0,0,2
343,Aryl Hydrocarbon Receptor Netpath WP2586,0.9314862725946041,0.3653581267217631,0.025930864088383507,['PLAGL1'],0.999266570014494,0,0,1
344,IL-3 signaling pathway WP286,0.9314862725946041,0.3653581267217631,0.025930864088383507,['BAD'],0.999266570014494,0,0,1
345,Pathogenic Escherichia coli infection WP2272,0.9314862725946041,0.3653581267217631,0.025930864088383507,['ARPC3'],0.999266570014494,0,0,1
346,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9314862725946041,0.3653581267217631,0.025930864088383507,['ATF2'],0.999266570014494,0,0,1
347,Osteoblast differentiation WP4787,0.9316676564157049,0.49755317146621497,0.03521637548986158,"['PRKCG', 'PRKCD', 'FGF1']",0.999266570014494,0,0,3
348,Insulin Signaling WP481,0.934570627814685,0.5579430942501482,0.03775493612750489,"['CYTH3', 'RAB4A', 'PRKCD', 'ENPP1', 'STX4']",0.999266570014494,0,0,5
349,22q11.2 copy number variation syndrome WP4657,0.9358157475120499,0.43805584281282317,0.029059167126338718,"['RANBP1', 'MRPL40']",0.999266570014494,0,0,2
350,Oncostatin M Signaling Pathway WP2374,0.9358157475120499,0.43805584281282317,0.029059167126338718,"['PRKCD', 'RPS6']",0.999266570014494,0,0,2
351,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9358157475120499,0.43805584281282317,0.029059167126338718,"['DEPTOR', 'TRIM28']",0.999266570014494,0,0,2
352,PI3K-Akt signaling pathway WP4172,0.940479103425292,0.6346242452166744,0.0389442556469361,"['ATF2', 'CDK6', 'ITGB5', 'BAD', 'PDGFC', 'RPS6', 'LPAR1', 'VEGFB', 'FGF1', 'NGF']",0.999266570014494,0,0,10
353,G13 Signaling Pathway WP524,0.9420694043079682,0.3424586776859504,0.020436676893326382,['ARHGDIG'],0.999266570014494,0,0,1
354,Circadian rhythm related genes WP3594,0.9437121849334902,0.5652594263615855,0.03274776683330437,"['PRKCG', 'NAMPT', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.999266570014494,0,0,6
355,Ras signaling WP4223,0.9437121849334902,0.5652594263615855,0.03274776683330437,"['PRKCG', 'RASA4', 'BAD', 'RASGRF2', 'KSR2', 'RASGRP2']",0.999266570014494,0,0,6
356,Joubert Syndrome WP4656,0.9440674857548392,0.42112799299976134,0.024239127622298046,"['CEP120', 'DVL3']",0.999266570014494,0,0,2
357,Focal Adhesion WP306,0.9489402114757546,0.5555731559216431,0.02911730240557826,"['PRKCG', 'ITGB5', 'BAD', 'PDGFC', 'VEGFB', 'TLN1']",0.999266570014494,0,0,6
358,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9510191610877462,0.3222532814778804,0.016183904053350864,['CHP1'],0.999266570014494,0,0,1
359,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.951303170015789,0.4054540579876671,0.02024127067220711,"['BAD', 'CYCS']",0.999266570014494,0,0,2
360,Endochondral Ossification with Skeletal Dysplasias WP4808,0.951303170015789,0.4054540579876671,0.02024127067220711,"['ENPP1', 'SLC38A2']",0.999266570014494,0,0,2
361,Endochondral Ossification WP474,0.951303170015789,0.4054540579876671,0.02024127067220711,"['ENPP1', 'SLC38A2']",0.999266570014494,0,0,2
362,DNA damage response (only ATM dependent) WP710,0.95259025107803,0.455831608005521,0.02213993478430263,"['BCL6', 'BAD', 'DVL3']",0.999266570014494,0,0,3
363,AMP-activated protein kinase (AMPK) signaling WP1403,0.957639630937294,0.390899689762151,0.016919600500283107,"['CPT1B', 'PPARGC1B']",0.999266570014494,0,0,2
364,Genes related to primary cilium development (based on CRISPR) WP4536,0.9581159907313171,0.4434278999496391,0.01897269787452349,"['CEP120', 'CEP83', 'WDR34']",0.999266570014494,0,0,3
365,Disruption of postsynaptic signaling by CNV WP4875,0.9585874128695921,0.3042929292929293,0.012869924322883447,['CAMK2A'],0.999266570014494,0,0,1
366,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9585874128695921,0.3042929292929293,0.012869924322883447,['ZMPSTE24'],0.999266570014494,0,0,1
367,TGF-beta Signaling Pathway WP366,0.9630334021386275,0.43167701863354035,0.016260056948394153,"['ATF2', 'PARD6A', 'SUMO1']",0.999266570014494,0,0,3
368,Leptin signaling pathway WP2034,0.9631818601616491,0.3773490710694291,0.014155509851193153,"['BAD', 'RPS6']",0.999266570014494,0,0,2
369,TNF-alpha signaling pathway WP231,0.9631818601616491,0.3773490710694291,0.014155509851193153,"['BAD', 'KSR2']",0.999266570014494,0,0,2
370,"GPCRs, Other WP117",0.9649872246947088,0.2882231404958678,0.010272392740251357,['GPR61'],0.999266570014494,0,0,1
371,Interferon type I signaling pathways WP585,0.9649872246947088,0.2882231404958678,0.010272392740251357,['RPS6'],0.999266570014494,0,0,1
372,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9649872246947088,0.2882231404958678,0.010272392740251357,['CAMK4'],0.999266570014494,0,0,1
373,TGF-beta Receptor Signaling WP560,0.9649872246947088,0.2882231404958678,0.010272392740251357,['LEFTY1'],0.999266570014494,0,0,1
374,Integrin-mediated Cell Adhesion WP185,0.9680238812300862,0.364701826956222,0.011852270097918578,"['ITGB5', 'TLN1']",0.999266570014494,0,0,2
375,Phosphodiesterases in neuronal function WP4222,0.9703988300372759,0.2737603305785124,0.008225985181602705,['PDE7B'],0.999266570014494,0,0,1
376,Cell cycle WP179,0.9712829546364317,0.40993788819875776,0.011944543797437066,"['CDK6', 'PCNA', 'E2F3']",0.999266570014494,0,0,3
377,Chemokine signaling pathway WP3929,0.9747221939324389,0.3998636570216634,0.010237620394776699,"['GRK4', 'PRKCD', 'RASGRP2']",0.999266570014494,0,0,3
378,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9749746854519622,0.2606749311294766,0.006606486010329076,['LEFTY1'],0.999266570014494,0,0,1
379,Prolactin Signaling Pathway WP2037,0.9788437477499184,0.24877911344853493,0.005319706754425662,['RPS6'],0.999266570014494,0,0,1
380,ESC Pluripotency Pathways WP3931,0.9791428630483423,0.33135909247594875,0.006984294028713153,"['DVL3', 'FGF1']",0.999266570014494,0,0,2
381,Androgen receptor signaling pathway WP138,0.9843636901904258,0.31230610134436404,0.004921896175884119,"['SUMO1', 'PARK7']",0.999266570014494,0,0,2
382,Endoderm differentiation WP2853,0.9867985349240835,0.3560626519038617,0.00473185152948144,"['SOX2', 'DUSP4', 'TCEAL2']",0.999266570014494,0,0,3
383,Male infertility WP4673,0.9891964580868209,0.21034647171010806,0.0022848515121470154,['TEX15'],0.999266570014494,0,0,1
384,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9908678602383831,0.20251760024487298,0.0018579153722343988,['RPS6'],0.999266570014494,0,0,1
385,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9922808449382262,0.1952479338842975,0.0015129961449084621,['EIF2B5'],0.999266570014494,0,0,1
386,Nuclear Receptors Meta-Pathway WP2882,0.9948903250371792,0.4276787591394333,0.0021909016243246344,"['PSMC5', 'GSTP1', 'SLC39A11', 'BLVRB', 'PPARA', 'SQSTM1', 'CES2']",0.999266570014494,0,0,7
387,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9976211250609903,0.1559917355371901,0.000371526913810299,['PPARGC1B'],0.999266570014494,0,0,1
388,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.999266570014494,0.12982093663911845,9.524950136908391e-05,['SESN3'],0.999266570014494,0,0,1
